US 12037616
Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related conditions
granted A61PA61P3/00
Quick answer
US patent 12037616 (Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related conditions) held by CRISPR THERAPEUTICS AG expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P3/00